40360_2018_200_MOESM3_ESM.pdf (1.06 MB)
Additional file 3: of A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
journal contribution
posted on 2018-03-16, 05:00 authored by Melissa Palmer, Lee Jennings, Debra Silberg, Caleb Bliss, Patrick MartinFigure S1. Frequency of stool hardness during treatment (Bristol Stool Chart scores). (PDF 1081 kb)